⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NMRA News
Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
NMRA
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
globenewswire.com
NMRA
Form 8-K
sec.gov
NMRA
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
NMRA
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
globenewswire.com
NMRA
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
businesswire.com
NMRA
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
globenewswire.com
NMRA
LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
globenewswire.com
LBRX
NMRA
AMGN
ABT
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
globenewswire.com
NMRA
INVESTOR ALERT AND NOTICE: Kaskela Law Firm Announces Investigation of Neumora Therapeutics, Inc. (NASDAQ:NMRA) and Encourages Long-Term Neumora Investors With Losses to Contact The Firm
accessnewswire.com
NMRA